6523.T Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 09:15):

PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products...

Stats
Šios dienos apimtis	160 100
Vidutinė apimtis	486 719
Rinkos kapitalizacija	141.41B
EPS	¥0 ( 2024-02-08 )
Kita pelno data	( ¥18.80 ) 2024-05-09
Last Dividend	¥36.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	-7.91
ATR14	¥0.645 (0.06%)

Tūris Koreliacija

Ilgas: -0.12 (neutral)

Trumpas: -0.68 (moderate negative)

Signal:(29.376) Neutral

PHC Holdings Corporation Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

PHC Holdings Corporation Koreliacija - Valiuta/Žaliavos

-0.21
( neutral )

-0.25
( neutral )

0.24
( neutral )

-0.15
( neutral )

-0.31
( neutral )

0.22
( neutral )

PHC Holdings Corporation Finansinės ataskaitos

Annual	2022
Pajamos:	¥356.43B
Bruto pelnas:	¥169.13B (47.45 %)
EPS:	¥-25.83

FY	2022
Pajamos:	¥356.43B
Bruto pelnas:	¥169.13B (47.45 %)
EPS:	¥-25.83

FY	2022
Pajamos:	¥340.45B
Bruto pelnas:	¥165.24B (48.53 %)
EPS:	¥-69.44

FY	2021
Pajamos:	¥306.07B
Bruto pelnas:	¥143.65B (46.93 %)
EPS:	¥142.35

Financial Reports:

No articles found.

PHC Holdings Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥36.00 (N/A)	¥0 (N/A)	¥36.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

PHC Holdings Corporation Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.10 - low (36.16%) | Divividend Growth Potential Score: 2.05 - Decrease likely (58.94%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥38.00	2022-03-30
Last Dividend	¥36.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	¥110.00	--
Avg. Dividend % Per Year	0.00%	--
Score	1.96	--
Div. Sustainability Score	4.10
Div.Growth Potential Score	2.05
Div. Directional Score	3.07	--

Next Divdend (Est)
(2024-07-01)

¥0 Estimate 1.50 %

Dividend Stability

0.12 Bad

Dividend Score

1.96

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
9760.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
8835.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
8285.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7673.T	Ex Dividend Junior	2024-05-30	Annually	0.00%
6855.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6203.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
4929.T	Ex Dividend Junior	2024-03-18	Annually	0.00%
4099.T	Ex Dividend Junior	2023-12-28	Semi-Annually	0.00%
3315.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
2384.T	Ex Dividend Junior	2023-12-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0511	1.500	-1.022	-1.533	[0 - 0.5]
returnOnAssetsTTM	-0.0329	1.200	-1.095	-1.315	[0 - 0.3]
returnOnEquityTTM	-0.128	1.500	-2.54	-3.81	[0.1 - 1]
payoutRatioTTM	-0.510	-1.000	-5.10	5.10	[0 - 1]
currentRatioTTM	1.306	0.800	8.47	6.78	[1 - 3]
quickRatioTTM	0.822	0.800	9.87	7.90	[0.8 - 2.5]
cashRatioTTM	0.325	1.500	9.31	10.00	[0.2 - 2]
debtRatioTTM	0.530	-1.500	1.171	-1.756	[0 - 0.6]
interestCoverageTTM	-0.429	1.000	-1.270	-1.270	[3 - 30]
operatingCashFlowPerShareTTM	341.98	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	224.85	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	2.30	-1.500	0.805	-1.207	[0 - 2.5]
grossProfitMarginTTM	0.454	1.000	5.76	5.76	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0188	1.000	-2.38	-2.38	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.150	1.000	-0.276	-0.276	[0.2 - 2]
assetTurnoverTTM	0.643	0.800	9.04	7.24	[0.5 - 2]
Total Score				4.10

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-7.95	1.000	-0.904	0	[1 - 100]
returnOnEquityTTM	-0.128	2.50	-1.631	-3.81	[0.1 - 1.5]
freeCashFlowPerShareTTM	224.85	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	6.42	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	341.98	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	-0.510	1.500	-5.10	5.10	[0 - 1]
pegRatioTTM	-0.125	1.500	-4.17	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.124	1.000	9.41	0	[0.1 - 0.5]
Total Score				2.05

PHC Holdings Corporation

PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies. In addition, the company engages in clinical testing, diagnostic reagents, and drug development support businesses. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. The company was founded in 2014 and is headquartered in Tokyo, Japan.